Company
MUVON Therapeutics AG
Incorporated
October 2020
Headquarter
Zurich
Support
Regain control with MUVON
MUVON enables healthy aging! We reverse age- or damage-related disability through functional skeletal muscle regeneration. MUVON's proprietary, tissue engineering regenerative platform technology induces successful muscle restoration, using a low-risk, minimally-invasive treatment modality, bringing personalized medicine to patients with high unmet medical need. In our first pipeline indication, we successfully completed PhI+PhII clinical trials, resulting in functional restoration of the sphincter muscle of patients, suffering from a highly-debilitating disease,stress urinary incontinence, affecting 40% women over 40 and 20% men over 60. Our platform therapy holds potential for a transformative therapeutic option. No raising SerA.
